tiprankstipranks
Trending News
More News >
Enliven Therapeutics (ELVN)
NASDAQ:ELVN
US Market

Enliven Therapeutics (ELVN) Technical Analysis

Compare
286 Followers

Technical Sentiment

Overall Consensus
Strong Sell
0Bullish
0Neutral
13Bearish
Technical Analysis Consensus
Strong Sell
0Bullish
0Neutral
1Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Enliven Therapeutics’s (ELVN) Moving Averages Convergence Divergence (MACD) indicator is -0.27, suggesting Enliven Therapeutics is a Buy.
Enliven Therapeutics’s (ELVN) 20-Day exponential moving average is 19.02, while Enliven Therapeutics’s (ELVN) share price is $14.91, making it a Sell.
Enliven Therapeutics’s (ELVN) 50-Day exponential moving average is 20.41, while Enliven Therapeutics’s (ELVN) share price is $14.91, making it a Sell.

Enliven Therapeutics (ELVN) Pivot Points

Apr 11, 2025, 07:53 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
17.37
18.43
19.05
20.11
20.73
21.79
22.41
Fibonacci
18.43
19.07
19.46
20.11
20.75
21.14
21.79
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Enliven Therapeutics (ELVN) Moving Averages

Apr 11, 2025, 07:53 PM
Period
Simple
Exponential
MA5
16.76Sell
16.62Sell
MA10
18.33Sell
17.85Sell
MA20
19.71Sell
19.02Sell
MA50
20.64Sell
20.41Sell
MA100
22.00Sell
21.59Sell
MA200
23.32Sell
22.29Sell
Enliven Therapeutics’s (ELVN) 10-Day exponential moving average is 17.85, while Enliven Therapeutics’s (ELVN) share price is $14.91, making it a Sell.
Enliven Therapeutics’s (ELVN) 100-Day exponential moving average is 21.59, while Enliven Therapeutics’s (ELVN) share price is $14.91, making it a Sell.
Enliven Therapeutics’s (ELVN) stock price is $14.91 and Enliven Therapeutics’s (ELVN) 50-day simple moving average is 20.64, creating a Sell signal.
Enliven Therapeutics’s (ELVN) stock price is $14.91 and Enliven Therapeutics’s (ELVN) 100-day simple moving average is 22.00, creating a Sell signal.
Enliven Therapeutics’s (ELVN) stock price is $14.91 and Enliven Therapeutics’s (ELVN) 200-day simple moving average is 23.32, creating a Sell signal.

Enliven Therapeutics (ELVN) Technical Indicators

Apr 11, 2025, 07:53 PM
Name
Value
Implied Action
RSI (14)
38.59
Neutral
STOCH (9,6)
17.93
Buy
STOCHRSI (14)
22.52
Neutral
MACD (12,26)
-0.27
Buy
ADX (14)
9.72
Buy
Williams %R
-87.89
Buy
CCI (14)
-269.48
Buy
ATR (14)
1.25
-
Ultimate Oscillator
41.81
Neutral
ROC
-29.27
Sell
Enliven Therapeutics’s (ELVN) Relative Strength Index (RSI) is 38.59, creating a Neutral signal.
Enliven Therapeutics’s (ELVN) Trend Strength Indicator (ADX) is 9.72, creating a Buy signal.
Enliven Therapeutics’s (ELVN) Commodity Channel Index (CCI) is -269.48, creating a Buy signal.
Enliven Therapeutics’s (ELVN) Price Rate of Change (ROC) is -29.27, creating a Sell signal.

FAQ

Is ELVN a Buy, Hold, or Sell?
Based on ELVN’s technical indicators, ELVN is a Strong Sell.
    What is ELVN’s RSI (14)?
    ELVN’s RSI (14) is 38.59, which suggests ELVN is a Neutral.
      What is ELVN’s MACD?
      ELVN’s MACD is -0.27, which suggests ELVN is a Buy.
        What is ELVN’s 5-day moving average?
        ELVN’s 5-day moving average is 16.76, which suggests ELVN is a Sell.
          What is ELVN’s 20-day moving average?
          ELVN 20-day moving average is 19.71, which suggests ELVN is a Sell.
            What is ELVN’s 50-day moving average?
            ELVN’s 50-day moving average is 20.64, which suggests ELVN is a Sell.
              What is ELVN’s 200-day moving average?
              ELVN’s 200-day moving average is 23.32, which suggests ELVN is a Sell.
                What is ELVN’s Williams % R (14)?
                ELVN’s Williams % R (14) is -87.89, which suggests ELVN is a Buy.
                  What is ELVN’s CCI (14)?
                  ELVN’s CCI (14) is -269.48, which suggests ELVN is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis